Your session is about to expire
← Back to Search
PUSH Plus Protein for Hip Fracture
N/A
Waitlist Available
Research Sponsored by University of Maryland, Baltimore
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 16 weeks
Awards & highlights
Study Summary
This trial is testing a 16-week, multi-part exercise intervention for hip fracture patients that will be supervised by specially trained physical therapists. The intervention uses a machine to provide strength and endurance training in the home and includes protein supplementation.
Eligible Conditions
- Hip Fracture
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 16 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~16 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Distance walked in six minutes
Secondary outcome measures
Activities of daily living (ADLs)
Balance
Bone mineral density (BMD)
+16 moreOther outcome measures
Adherence with PUSH intervention
Adherence with protein supplement
Adherence with study vitamins/supplements
+2 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: PUSH Plus Protein and NutritionExperimental Treatment3 Interventions
Participants will be given a whey-based protein supplement containing 27.6g of protein daily for 16 weeks and receive the PUSH intervention. PUSH is a specific multi-component intervention based on improving specific precursors to community ambulation. The intervention addresses endurance with continuous upright exercise for 20 min.; function by improving fast walking, standing from a chair, and stair negotiation; muscle performance by exercising to enhance lower extremity strength; and balance by performing unilateral activities and activities with decreased base of support. Participants receive 32 visits of approximately 60 minutes in duration from a study PT. Participants will receive two visits a week, on non-consecutive days, for 16 weeks. Visits take place in the participant's place of residence. Participants also receive the nutritional intervention for the duration of the 16-week study.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Protein
2016
Completed Phase 3
~1100
PUSH
2013
N/A
~210
Nutrition
2011
Completed Phase 3
~58070
Find a Location
Who is running the clinical trial?
University of Maryland, BaltimoreLead Sponsor
687 Previous Clinical Trials
374,626 Total Patients Enrolled
4 Trials studying Hip Fracture
749 Patients Enrolled for Hip Fracture
National Institute on Aging (NIA)NIH
1,668 Previous Clinical Trials
28,005,044 Total Patients Enrolled
4 Trials studying Hip Fracture
635 Patients Enrolled for Hip Fracture
Jay Magaziner, PhD, MSHygStudy ChairUniversity of Maryland, Baltimore
1 Previous Clinical Trials
210 Total Patients Enrolled
1 Trials studying Hip Fracture
210 Patients Enrolled for Hip Fracture
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: PUSH Plus Protein and Nutrition
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are participants being actively sought for this research endeavor?
"Based on the information hosted by clinicaltrials.gov, enrollment in this particular study has been concluded. The trial was first posted July 16th 2018 and last amended April 25th 2022; yet, 365 other studies are actively recruiting participants presently."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger